BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28356444)

  • 1. Antibody-Mediated Inhibition of Tspan12 Ameliorates Vasoproliferative Retinopathy Through Suppression of β-Catenin Signaling.
    Bucher F; Zhang D; Aguilar E; Sakimoto S; Diaz-Aguilar S; Rosenfeld M; Zha Z; Zhang H; Friedlander M; Yea K
    Circulation; 2017 Jul; 136(2):180-195. PubMed ID: 28356444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
    Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
    Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
    Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
    Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
    Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Kolibabka M; Dietrich N; Klein T; Hammes HP
    Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies targeting Frizzled-7/β-catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model.
    Bats ML; Bougaran P; Peghaire C; Gueniot F; Abelanet A; Chan H; Séguy C; Jeanningros S; Jaspard-Vinassa B; Couffinhal T; Duplàa C; Dufourcq P
    FASEB J; 2020 Jan; 34(1):1288-1303. PubMed ID: 31914666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
    Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
    Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
    Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
    Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.
    Knoblich K; Wang HX; Sharma C; Fletcher AL; Turley SJ; Hemler ME
    Cell Mol Life Sci; 2014 Apr; 71(7):1305-14. PubMed ID: 23955570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
    Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
    Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy.
    Bucher F; Walz JM; Bühler A; Aguilar E; Lange C; Diaz-Aguilar S; Martin G; Schlunck G; Agostini H; Friedlander M; Stahl A
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4017-26. PubMed ID: 27494343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
    Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
    Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
    Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
    Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.